Evidence map›Paper›PMID 40929010›Full record

ArticlePloS one2025

Predicting the future risk and outcomes of severe heart failure and coronary artery disease with machine learning in the UK Biobank Cohort.

Karim Taha, Heather J Ross, Mohammad Peikari, Brigitte Mueller, Chun-Po S Fan, Edgar Crowdy, Yas Moayedi, Filio Billia, Cedric Manlhiot

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karim TahaDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Heather J RossDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Mohammad PeikariDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Brigitte MuellerDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-1876-4722
Chun-Po S FanDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Edgar CrowdyDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Yas MoayediDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Filio BilliaDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Cedric ManlhiotDepartment of Medicine, The Red Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0001-9419-7681

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn order to seriously impact the global burden of heart failure (HF) and coronary artery disease (CAD), identifying at-risk individuals as early as possible is vital. Risk calculator tools in wide clinical use today are informed by traditional statistical methods that have historically yielded only modest prediction accuracy.

methodsThis study uses machine learning algorithms to generate predictions models for the development and progression of severe HF and CAD. Participants (~485,000 followed in the UK Biobank over 7 years) were stratified by cardiac status at the time of enrollment (asymptomatic, high-risk and affected); separate prediction models were built for each stratum. Participants were split between a training set (80%) and holdout dataset (20%), all performance metrics are reported for the holdout dataset.

resultsOut of 6 machine learning algorithms screened, artificial neural networks (ANN) most successfully predicted future disease across the various strata (area under the curve: 0.77-0.86 for 10/12 models), results were very consistent between methodologies. Models trained using ANN showed excellent calibration in all strata and across the entire spectrum of risk (0.4-1.2% average observed/predicted difference across 10 deciles of risk). Key predictive features included age, frailty, adiposity, history of hypertension and diabetes, tobacco use and family history of heart disease and were consistent between models for HF and CAD.

conclusionsWhen deployed as a patient-facing application, the prediction models presented here will be able to provide both user-specific predictions and simulate the effect of changes in lifestyle and of prophylaxis interventions, thus resulting in an individualized patient counselling and management tool.

Indexed as

Coronary Artery DiseaseHeart FailureMachine LearningAgedAlgorithmsBiological Specimen BanksCohort StudiesFemaleHumansMaleMiddle AgedNeural Networks, ComputerRisk AssessmentRisk FactorsUK BiobankUnited Kingdom

Identifiers

PMID40929010
PMCPMC12422514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.